Pharmacotherapeutics. Review and commentary.
D000082:Acetaminophen / Q000627:therapeutic use; D000083:Acetanilides / Q000009:adverse effects; D000661:Amphetamine / Q000009:adverse effects / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002653:Child Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D004358:Drug Therapy; D004917:Erythromycin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D010372:Pediatrics; D010406:Penicillins / Q000627:therapeutic use; D013752:Tetracycline / Q000009:adverse effects
D000083:Acetanilides; D000700:Analgesics; D000900:Anti-Bacterial Agents; D010406:Penicillins; D008774:Methylphenidate; D000082:Acetaminophen; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D000661:Amphetamine; D013752:Tetracycline; D001241:Aspirin